Utility of the MoCA for cognitive impairment screening in long-term psychosis patients-Reference-Cited by-同舟云学术

Utility of the MoCA for cognitive impairment screening in long-term psychosis patients

Published:2020-02 Issue: Volume:216 Page:429-434
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Gil-Berrozpe Gustavo J.,Sánchez-Torres Ana M.,García de Jalón Elena,Moreno-Izco Lucia,Fañanás Lourdes,Peralta Victor,Cuesta Manuel J.,Ballesteros Alejandro,Hernández Rebeca,Janda Lucía,Llano Katia,López-Gil José,López-Ilundain José,Macaya Patricia,Martínez-Parreño Elena,Papiol Sergi,Peralta David,Ribeiro María,Rosero Ángela S.,Saiz Héctor

Funder

Department of Health of the Government of Navarra

Carlos III Health Institute

Spanish Ministry of Economy and Competitivity

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference37 articles.

1. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology;Andreasen;Arch. Gen. Psychiatr.,1992

2. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates;Bilder;Am. J. Psychiatry,2000

3. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder;Bilder;Am. J. Psychiatry,2002